SEC Form 4 · accession 0001209191-18-015950
Odonate Therapeutics, Inc. · ODT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Kevin C Tang
Officer — Chief Executive Officer · Director · 10% Owner
TANG CAPITAL PARTNERS LP
10% Owner
TANG CAPITAL MANAGEMENT LLC
10% Owner
John G Lemkey
Officer — Chief Financial Officer
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2018 | P | 4,050 | $27.7302 | A | 12,402,338 | I | By LP |
| Common StockF1 | Feb 28, 2018 | P | 5,599 | $27.0362 | A | 12,407,937 | I | By LP |
| Common StockF1 | Mar 1, 2018 | P | 4,401 | $27.6071 | A | 12,412,338 | I | By LP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. The shares reported as beneficially owned by TCP include a total of 154,285 shares of common stock that are held of record by Odonate Holdings, LLC ("Holdings"). Holdings has granted a proxy to TCP giving TCP the sole authority to vote such shares. John G. Lemkey is the Chief Financial Officer of Odonate Therapeutics, Inc., as well as Chief Operating Officer of TCM. Mr. Lemkey has a pecuniary interest in a portion of the shares beneficially held by TCP.